X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (32) 32
index medicus (30) 30
female (28) 28
male (24) 24
aged (23) 23
middle aged (21) 21
adult (16) 16
chemotherapy (16) 16
cancer (13) 13
oncology (13) 13
retrospective studies (13) 13
analysis (10) 10
lung cancer (10) 10
prognosis (10) 10
medicine, general & internal (9) 9
survival (9) 9
treatment outcome (9) 9
aged, 80 and over (7) 7
care and treatment (7) 7
lung neoplasms - mortality (7) 7
diagnosis (6) 6
disease (6) 6
hematology (6) 6
lung neoplasms - drug therapy (6) 6
metastasis (6) 6
neoplasm staging (6) 6
original (6) 6
therapy (6) 6
abridged index medicus (5) 5
adolescent (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
cancer therapies (5) 5
chemistry (5) 5
cisplatin (5) 5
disease-free survival (5) 5
original article (5) 5
patients (5) 5
survival analysis (5) 5
antineoplastic agents - adverse effects (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
carboplatin (4) 4
clinical neurology (4) 4
follow-up studies (4) 4
health care sciences & services (4) 4
kaplan-meier estimate (4) 4
lung neoplasms - pathology (4) 4
magnetic resonance imaging (4) 4
medical prognosis (4) 4
non-small cell lung cancer (4) 4
nutrition (4) 4
respiratory system (4) 4
tomography, x-ray computed (4) 4
trial (4) 4
usage (4) 4
anesthesia & perioperative care (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic agents - therapeutic use (3) 3
carcinoma, non-small-cell lung - diagnosis (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
carcinoma, non-small-cell lung - mortality (3) 3
cisplatin - administration & dosage (3) 3
cisplatin - adverse effects (3) 3
clinical trials (3) 3
cyclophosphamide - administration & dosage (3) 3
docetaxel (3) 3
drug administration schedule (3) 3
drug therapy, combination (3) 3
etoposide (3) 3
food science (3) 3
food science & technology (3) 3
further section (3) 3
immunohistochemistry (3) 3
inflammation (3) 3
lung cancer, non-small cell (3) 3
lung cancer, small cell (3) 3
lung neoplasms - blood (3) 3
lung neoplasms - diagnosis (3) 3
lymphocyte (3) 3
lymphocytes (3) 3
medical research (3) 3
medicine & public health (3) 3
mortality (3) 3
multiple myeloma (3) 3
multivariate analysis (3) 3
pain medicine (3) 3
platinum (3) 3
proteins (3) 3
research (3) 3
research article (3) 3
risk factors (3) 3
small cell lung carcinoma (3) 3
small cell lung carcinoma - mortality (3) 3
solid tumors (3) 3
studies (3) 3
식품과학 (3) 3
5700 (2) 2
animals (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - adverse effects (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 389 - 400
Journal Article
Journal of Pain and Symptom Management, ISSN 0885-3924, 2012, Volume 43, Issue 3, pp. 625 - 630
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 2014, Volume 15, Issue 8, pp. 14475 - 14491
Journal Article
by Paz-Ares, Luis and Dvorkin, Mikhail and Chen, Yuanbin and Reinmuth, Niels and Hotta, Katsuyuki and Trukhin, Dmytro and Statsenko, Galina and Hochmair, Maximilian J and Özgüroğlu, Mustafa and Ji, Jun Ho and Voitko, Oleksandr and Poltoratskiy, Artem and Ponce, Santiago and Verderame, Francesco and Havel, Libor and Bondarenko, Igor and Kazarnowicz, Andrzej and Losonczy, György and Conev, Nikolay V and Armstrong, Jon and Byrne, Natalie and Shire, Norah and Jiang, Haiyi and Goldman, Jonathan W and Batagelj, Emilio and Casarini, Ignacio and Pastor, Anea Viviana and Sena, Susana Noemi and Zarba, Juan Jose and Burghuber, Otto and Hartl, Sylvia and Hochmair, Maximilian J and Lamprecht, Bernd and Studnicka, Michael and Alberto Schlittler, Luis and Augusto Martinelli de Oliveira, Fabricio and Calabrich, Aknar and Colagiovanni Girotto, Gustavo and Dos Reis, Peo and Fausto Nino Gorini, Carlos and Rafael Martins De Marchi, Peo and Serodio da Rocha Baldotto, Clarissa and Sette, Claudia and Zukin, Mauro and Conev, Nikolay V and Dudov, Assen and Ilieva, Rumyana and Koynov, Krassimir and Krasteva, Rositsa and Tonev, Ivan and Valev, Spartak and Venkova, Violetka and Bi, Minghong and Chen, Chengshui and Chen, Yuan and Chen, Zhendong and Fang, Jian and Feng, Jifeng and Han, Zhigang and Hu, Jie and Hu, Yi and Li, Wei and Liang, Zongan and Lin, Zhong and Ma, Rui and Ma, Shenglin and Nan, Kejun and Shu, Yongqian and Wang, Kai and Wang, Mengzhao and Wu, Gang and Yang, Nong and Yang, Zhixiong and Zhang, Helong and Zhang, Wei and Zhao, Jun and Zhao, Yanqiu and Zhou, Caicun and Zhou, Jianying and Zhou, Xiangdong and Havel, Libor and Kolek, Vitezslav and Koubkova, Leona and Roubec, Jaromir and Skrickova, Jana and Zemanova, Milada and Chouaid, Christos and Hilgers, Werner and Lena, Hervé and Moro-Sibilot, Denis and Robinet, Gilles and Souquet, Pierre-Jean and Alt, Jürgen and Bischoff, Helge and Grohe, Christian and Laack, Eckart and Lang, Susanne and Panse, Jens and Reinmuth, Niels and Schulz, Christian and ... and CASPIAN investigators and CASPIAN Investigators
The Lancet, ISSN 0140-6736, 11/2019, Volume 394, Issue 10212, pp. 1929 - 1939
Most patients with small-cell lung cancer (SCLC) have extensive-stage disease at presentation, and prognosis remains poor. Recently, immunotherapy has... 
PROPHYLACTIC CRANIAL IRRADIATION | SCLC | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | CISPLATIN | Antineoplastic Agents, Immunological - administration & dosage | Lung Neoplasms - drug therapy | Etoposide - adverse effects | Drug Administration Schedule | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols | Carboplatin - administration & dosage | Etoposide - administration & dosage | Male | Small Cell Lung Carcinoma - drug therapy | Cisplatin - administration & dosage | Carboplatin - adverse effects | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Agents, Phytogenic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal - administration & dosage | Progression-Free Survival | Cisplatin - adverse effects | Female | Small Cell Lung Carcinoma - mortality | Aged | Etoposide | Care and treatment | Product development | Lung cancer | Analysis | Drugs | Medical services | Radiation | Clinical trials | Metastasis | Cancer therapies | Randomization | Motivation | Platinum | Immunotherapy | Safety | Neutropenia | Small cell lung carcinoma | Maintenance | Radiation therapy | Survival | Patients | Cisplatin | Response rates | Carboplatin | Irradiation | Ligands | Clinical medicine | Solid tumors | Tumors | Apoptosis
Journal Article
by Shin, H and Park, S and Lee, GW and Koh, EH and Kim, HY
MEDICINE, ISSN 0025-7974, 08/2019, Volume 98, Issue 35, p. e16993
Rationale: Parvovirus B19 (PV) infection is usually symptomless and can cause benign, short-lived conditions. Anemia associated with PRCA is the most... 
MEDICINE, GENERAL & INTERNAL | thrombocytopenia | RITUXIMAB | DISEASE | neutropenia | pure red cell aplasia | parvovirus B19 | Polymerase chain reaction | Thrombocytopenia | Usage | Research | Diagnosis | Parvovirus infections | Neutropenia
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 29, pp. 47007 - 47019
Backgrounds: Sarcopenia is known to be associated with poor clinical outcome in patients with diffuse large B-cell lymphoma (DLBCL). There is no consensus... 
Sarcopenia | Muscle | Prognosis | Drug toxicity | Diffuse large B-cell lymphoma | R-CHOP | NCCN-IPI | diffuse large B-cell lymphoma | RANDOMIZED CONTROLLED-TRIAL | prognosis | CHEMOTHERAPY PLUS RITUXIMAB | CELL BIOLOGY | CHOP-LIKE CHEMOTHERAPY | NEOADJUVANT CHEMOTHERAPY | drug toxicity | muscle | BODY-MASS INDEX | INDEPENDENT PROGNOSTIC-FACTOR | ELDERLY-PATIENTS | sarcopenia | CLINICAL-OUTCOMES | Doxorubicin - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Sarcopenia - mortality | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Neoplasm Metastasis | Lumbosacral Region | Sarcopenia - etiology | Aged, 80 and over | Female | Retrospective Studies | Back Muscles - pathology | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Lymphoma, Large B-Cell, Diffuse - pathology | Kaplan-Meier Estimate | Sarcopenia - diagnosis | Lymphoma, Large B-Cell, Diffuse - complications | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pectoralis Muscles - pathology | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Neoplasm Staging | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2015, Volume 90, Issue 11, pp. 1013 - 1020
Journal Article
Medicine, ISSN 0025-7974, 01/2017, Volume 96, Issue 1, p. e5408
Rationale: Nephropathy with concurrent invasive thymoma is a type of paraneoplastic syndrome. Patient concerns and Diagnoses: We report a 32-year-old female... 
Case reports | Nephrotic syndrome | Paraneoplastic syndromes | Thymoma | MEDICINE, GENERAL & INTERNAL | MALIGNANT THYMOMA | case reports | GLOMERULAR-DISEASES | paraneoplastic syndromes | thymoma | OF-THE-LITERATURE | NEPHROPATHY | CANCER | nephrotic syndrome | INVASIVE THYMOMA | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Kidney - pathology | Humans | Nephrotic Syndrome - metabolism | Tomography, X-Ray Computed - methods | Lung Neoplasms - pathology | Paraneoplastic Syndromes - diagnosis | Lung - diagnostic imaging | Cisplatin - administration & dosage | Lung Neoplasms - secondary | Glomerulosclerosis, Focal Segmental - etiology | Vincristine - administration & dosage | Adult | Female | Nephrotic Syndrome - therapy | Thymoma - drug therapy | Thymoma - pathology | Nephrotic Syndrome - diagnosis | Thymoma - surgery | Doxorubicin - administration & dosage | Paraneoplastic Syndromes - therapy | Lung - pathology | Neoplasm Invasiveness | Treatment Outcome | Paraneoplastic Syndromes - etiology | Glomerulosclerosis, Focal Segmental - diagnosis | Paraneoplastic Syndromes - metabolism | Disease Management | Glomerulosclerosis, Focal Segmental - therapy | Neoplasm Staging | Nephrotic Syndrome - etiology | Thymoma - physiopathology | Complications and side effects | Care and treatment | Chemotherapy | Usage | Diagnosis | Risk factors | Cancer
Journal Article
Journal Article